This suggests that the modification of the nanoparticles with the S2.2 aptamer, which has a affinity for MUC-1, increased the effectiveness of the PTX delivery system to MCF-7 breast cancer cells, resulting in increased MCF-7 cell death [208]. Here, MUC1 is linked to breast carcinoma.